Use of topical diclofenac in association with external ocular compression.
AI Summary
Topical diclofenac significantly enhanced intraocular pressure reduction during external ocular compression and reduced post-compression recovery, suggesting prostaglandins mediate these IOP changes and could be targeted.
Abstract
This study investigated the effect of pretreatment with topical diclofenac 0.1% on the changes in intraocular pressure (IOP) associated with use of an external ocular compression device. The IOP reduction in eyes receiving pretreatment was significantly greater than in controls after 40 minutes of compression, and the recovery in IOP after removal of the compression device was significantly reduced. We conclude that the IOP rise after such compression is largely prostaglandin mediated, and suggest that use of ocular compression devices is associated with marked intraocular prostaglandin release.
MeSH Terms
Shields Classification
Related Articles5
Aqueous Humor Dynamics Changes and Predictors of IOP Response to Latanoprost in Healthy Subjects.
Clinical TrialEffects of apraclonidine on aqueous humor dynamics in human eyes.
Randomized Controlled TrialEffects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Randomized Controlled TrialProstaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.
Clinical TrialProstaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow.
Randomized Controlled TrialIs this article assigned to the wrong chapter(s)? Let us know.